Health stocks: pent up demand returning in time

Nedbank Private Wealth’s Preston Narainsamy on Life Healthcare’s Alzheimer’s drug and Q1 GDP figures. Sygnia CEO David Hufton unpacks results as passive investing continues to grow. Omri Thomas, director of Abax Investments, talks mandate drift and equities for income.

AUTHOR PROFILE

COMMENTS   0

You must be signed in to comment.

SIGN IN SIGN UP

LATEST CURRENCIES  

USD / ZAR
GBP / ZAR
EUR / ZAR
BTC / USD
INSIDER SUBSCRIPTIONS APP VIDEOS RADIO / LISTEN LIVE SHOP OFFERS WEBINARS NEWSLETTERS TRENDING PORTFOLIO TOOL CPD HUB

Follow us:

Search Articles: Advanced Search
Click a Company: